The approval via Irish authorities is for BGG’s ‘supercritically extracted’ algae (Haematococcus pluvialis)-sourced astaxanthin made in Europe by BGG. It also offers ethanol extraction for the antioxidant.
“This is yet another regulatory accomplishment in a quickly escalating list that includes innovations such as the first NDI for Astaxanthin greater than 12mg per day dosage,” said Christian Artaria, CEO of BGG’s European operations and CMO for the Beijing-based BGG Group.